<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Pentoxifylline</id>
	<title>Pentoxifylline - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Pentoxifylline"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Pentoxifylline&amp;action=history"/>
	<updated>2026-04-17T19:27:47Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Pentoxifylline&amp;diff=122170&amp;oldid=prev</id>
		<title>Mholtz: Text replacement - &quot;--&gt;&quot; to &quot;→&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Pentoxifylline&amp;diff=122170&amp;oldid=prev"/>
		<updated>2017-02-08T18:27:37Z</updated>

		<summary type="html">&lt;p&gt;Text replacement - &amp;quot;--&amp;gt;&amp;quot; to &amp;quot;→&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;es&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Revisión anterior&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisión del 18:27 8 feb 2017&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l39&quot;&gt;Línea 39:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línea 39:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Mechanism of Action==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Inhibits phosphodiesterase, decreases plasma fibrinogen concentrations, and RBC/platelet &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;aggregation--&amp;gt; &lt;/del&gt;reduced blood viscosity, improved erythrocyte flexibility/microcirculatory flow&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Inhibits phosphodiesterase, decreases plasma fibrinogen concentrations, and RBC/platelet &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;aggregation→ &lt;/ins&gt;reduced blood viscosity, improved erythrocyte flexibility/microcirculatory flow&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Comments==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Comments==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mholtz</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Pentoxifylline&amp;diff=110501&amp;oldid=prev</id>
		<title>ClaireLewis: Created page with &quot;==Administration== *Type:  *Dosage Forms: *Routes of Administration: Oral  *Common Trade Names: Trental, Pentoxil  ==Adult Dosing== *Intermittent claudication, stasis ulcer: 4...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Pentoxifylline&amp;diff=110501&amp;oldid=prev"/>
		<updated>2016-11-14T00:45:54Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Administration== *Type:  *Dosage Forms: *Routes of Administration: Oral  *Common Trade Names: Trental, Pentoxil  ==Adult Dosing== *Intermittent claudication, stasis ulcer: 4...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Página nueva&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: &lt;br /&gt;
*Dosage Forms:&lt;br /&gt;
*Routes of Administration: Oral &lt;br /&gt;
*Common Trade Names: Trental, Pentoxil&lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
*Intermittent claudication, stasis ulcer: 400mg PO TID&lt;br /&gt;
*Vascular disorder of inner ear: 1600mg PO per day in 2-4 divided doses&lt;br /&gt;
*Non-alcoholic fatty liver: 1200mg PO daily&lt;br /&gt;
*Note: likely no benefit in acute alcoholic hepatitis&amp;lt;ref&amp;gt;Mathurin P, Louvet A, Duhamel A, et al. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA. 2013;310(10):1033-41.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
''Safety/efficacy not established''&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C&lt;br /&gt;
*[[Lactation risk categories|Lactation risk]]: Infant risk cannot be ruled out&lt;br /&gt;
*Renal dosing: no adjustment&lt;br /&gt;
*Hepatic dosing: no adjustment&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
*Recent cerebral or retinal hemorrhage&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*Aplastic anemia, thrombocytopenia&lt;br /&gt;
*Angina&lt;br /&gt;
*Jaundice&lt;br /&gt;
*Retinal hemorrhage&lt;br /&gt;
===Common===&lt;br /&gt;
*Nausea/vomiting&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: 0.4-1.6h&lt;br /&gt;
*Metabolism: Hepatic&lt;br /&gt;
*Excretion: &lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
*Inhibits phosphodiesterase, decreases plasma fibrinogen concentrations, and RBC/platelet aggregation--&amp;gt; reduced blood viscosity, improved erythrocyte flexibility/microcirculatory flow&lt;br /&gt;
&lt;br /&gt;
==Comments==&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
[[Category:Pharmacology]]&lt;/div&gt;</summary>
		<author><name>ClaireLewis</name></author>
	</entry>
</feed>